Daiichi Sankyo-controlled Ranbaxy Laboratories has sold its Vietnam business, as part of the company's ongoing restructuring operations. Ranbaxy may soon sell another of its business soon as it wants to divest of some of its loss making businesses, Ranbaxy CEO and MD Atul Sobti has stated. “We have divested the Vietnam operations ...